Archive - May 2022
AstraZeneca’s Imfinzi plus chemotherapy accepted for Priority Review in the US
University launches hub for pregnant women with pre-existing medical conditions
WHO recommends Veklury for high-risk patients
Flurona Symptoms: Woman Dies After Contracting Flu And COVID-19 Simultaneously
Enhertu Approved in the US for Patients with HER2-Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen
Farxiga demonstrates success in preserved ejection fraction trial
EC approval for post-steroid graft-versus-host treatment
The Michael J Fox Foundation gives Asceneuron second research grant